COT drives resistance to RAF inhibition through MAP kinase pathway reactivation : Nature : Nature Pu
Next, we examined COT expression in the context of resistance to the clinical RAF inhibitor PLX4032 by obtaining biopsy material from three patients with metastatic, B-RAF(V600E) melanoma. Each case consisted of frozen, lesion-matched biopsy material ......